83603-04-7 Usage
Uses
Used in Pharmaceutical Industry:
(+/-)-2-oxo-bornane-10-sulfonic acid methyl ester is used as a chiral resolving agent and catalyst for facilitating asymmetric synthesis and separation of enantiomers in the production of pharmaceuticals.
Used in Agrochemical Industry:
(+/-)-2-oxo-bornane-10-sulfonic acid methyl ester is used as a chiral resolving agent and catalyst in the synthesis of chiral compounds and pharmaceutical intermediates for agrochemicals.
Used in Functional Materials Industry:
(+/-)-2-oxo-bornane-10-sulfonic acid methyl ester is used as a chiral resolving agent and catalyst in the production of functional materials due to its ability to facilitate asymmetric synthesis and separation of enantiomers.
Check Digit Verification of cas no
The CAS Registry Mumber 83603-04-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,6,0 and 3 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 83603-04:
(7*8)+(6*3)+(5*6)+(4*0)+(3*3)+(2*0)+(1*4)=117
117 % 10 = 7
So 83603-04-7 is a valid CAS Registry Number.
83603-04-7Relevant academic research and scientific papers
SALTS OF TIOTROPIUM WITH 10-CAMPHORSULFONIC ACID
-
Page/Page column 6, (2012/03/27)
The present invention relates to novel tiotropium salts with 10-camphorsulphonic acid of formula (I), its optical isomers or their mixtures, their monohydrates, their anhydrous crystalline forms and processes for the preparation thereof, as well as to pharmaceutical compositions containing the same and to the use of novel salts for the treatment of respiratory tract diseases.
SALTS OF TIOTROPIUM WITH 10-CAMPHORSULFONIC ACID
-
Page/Page column 16-17, (2010/12/18)
The present invention relates to novel tiotropium salts with 10-camphorsulphonic acid of formula (I), its optical isomers or their mixtures, their monohydrates, their anhydrous crystalline forms and processes for the preparation thereof, as well as to pharmaceutical compositions containing the same and to the use of novel salts for the treatment of respiratory tract diseases. (I)
